Form D · Pharmaceuticals
Complexa Inc.
Berwyn, PA · CIK 0001551369
Offering snapshot reported Apr 16, 2019 · SEC filing
- Reported sold
- $11M Offering amount: $28M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 8, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 16, 2019 | Initial | $10,999,999 | No comparison | 4 | SEC filing |
| Jul 26, 2017 | Initial | $40,570,421 | No comparison | 28 | SEC filing |
| Nov 30, 2016 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
| Apr 4, 2016 | Initial | $950,000 | No comparison | 6 | SEC filing |
| Jun 15, 2015 | Initial | $4,000,000 | No comparison | 8 | SEC filing |
| Jun 5, 2014 | Initial | $14,765,747 | No comparison | 28 | SEC filing |
| Oct 23, 2013 | Initial | $3,175,000 | No comparison | 5 | SEC filing |
| May 1, 2013 | Initial | $1,400,000 | No comparison | 5 | SEC filing |
| Jun 1, 2012 | Initial | $2,042,458 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-337393
Source: Form D, filed Apr 16, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Barbara Dalton | Director |
| Peter Grebow | Director |
| Kenji Harada | Director |
| Hironori Hozoji | Director |
| Diane Jorkasky | Executive |
| Bernardus N. Machielse | Director |
| Carter Meyer | Director |
| I. Wistar Morris | Director |
| David Mott | Director |
| Sara M. Nayeem | Director |
| Gilles M. Nobecourt | Director |
| Federica O'brien | Executive |
| Frederica O'brien | Executive |
| H. Joseph Reiser | Director |
| Harold Safferstein | Director |
| Francisco D. Salva | Director, Executive |
| Joshua M. Tarnoff | Director, Executive |
| Miwa Toyoda | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1055 Westlakes Drive Suite 200
Berwyn, PA, 19312
Berwyn, PA, 19312